These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37629142)

  • 1. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
    Choudhry M; Gamallat Y; Ghosh S; Bismar TA
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
    Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
    Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
    PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Zhang M; Lin H; Ge X; Xu Y
    J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
    Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Choudhry M; Gamallat Y; Khosh Kish E; Seyedi S; Gotto G; Ghosh S; Bismar TA
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
    Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
    Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro.
    Gamallat Y; Zaaluk H; Kish EK; Abdelsalam R; Liosis K; Ghosh S; Bismar TA
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Wang X; Dong J; Li X; Cheng Z; Zhu Q
    Oncogene; 2021 Jun; 40(25):4338-4351. PubMed ID: 34103682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
    Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
    Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
    Nitschke K; Erben P; Waldbillig F; Abdelhadi A; Weis CA; Gottschalt M; Wahby S; Nuhn P; Boutros M; Michel MS; von Hardenberg J; Worst TS
    World J Urol; 2020 Mar; 38(3):637-645. PubMed ID: 30701334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m
    Luo Q; Zhan X; Kuang Y; Sun M; Dong F; Sun E; Chen B
    Med Oncol; 2022 Sep; 39(12):231. PubMed ID: 36175708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
    Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
    Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
    Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
    Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
    Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
    Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
    Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NEAT1 Regulates 5-Fu Sensitivity, Apoptosis and Invasion in Colorectal Cancer Through the MiR-150-5p/CPSF4 Axis.
    Wang X; Jiang G; Ren W; Wang B; Yang C; Li M
    Onco Targets Ther; 2020; 13():6373-6383. PubMed ID: 32669857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
    Zhang N; Xie Y; Tai Y; Gao Y; Guo W; Yu W; Li J; Feng X; Hao J; Gao Y; Zhao X; Liao Y; Jiang W; Liu G; Deng W; Cui X
    Cell Physiol Biochem; 2016; 40(6):1559-1569. PubMed ID: 27997899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.